Toll Free: 1-888-928-9744

Alliqua BioMedical, Inc. (ALQA) - Product Pipeline Analysis, 2016 Update

Published: Jun 8, 2016 | Pages: 36 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Alliqua BioMedical, Inc. (Alliqua BioMedical) formerly HepaLife Technologies Inc. is a medical device company that offers wound care solutions. The company offers wound care, transdermal drug delivery, and contract manufacturing solutions. Its wound care business manufactures and markets wound dressings that include BIOVANCE, SilverSeal, Hydress, sorbion sachet S, and sorbion sana gentle. Alliqua BioMedical's transdermal drug delivery business uses hydrogel technology to deliver therapeutic compounds through the skin. The company's contract manufacturing business unit provides custom hydrogels to the OEM market. It develops and manufactures electron-beam cross-linked sheet gels for manufacturers of medical devices, cosmeceuticals, and other commercial product applications. Alliqua BioMedical is headquartered in Yardley, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Alliqua BioMedical, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Alliqua BioMedical, Inc. Company Snapshot 6 Alliqua BioMedical, Inc. Company Overview 6 Alliqua BioMedical, Inc. Pipeline Products and Clinical Trials Overview 7 Alliqua BioMedical, Inc.- Pipeline Analysis Overview 9 Key Facts 9 Alliqua BioMedical, Inc. - Major Products and Services 10 Alliqua BioMedical, Inc. Pipeline Products by Development Stage 11 Alliqua BioMedical, Inc. Clinical Trials by Trial Status 13 Alliqua BioMedical, Inc. Pipeline Products Overview 14 Extracellular Matrix 14 Extracellular Matrix Product Overview 14 HepaMate 15 HepaMate Product Overview 15 HepaMate Bioartificial Liver System 16 HepaMate Bioartificial Liver System Product Overview 16 HepaMate Bioartificial Liver System Clinical Trial 17 Interfyl Human Connective Tissue Matrix 18 Interfyl Human Connective Tissue Matrix Product Overview 18 PHN Patch 19 PHN Patch Product Overview 19 PHN Patch Clinical Trial 20 SEPET Liver Assist Device 21 SEPET Liver Assist Device Product Overview 21 Tissue Repair Scaffold 22 Tissue Repair Scaffold Product Overview 22 Alliqua BioMedical, Inc. - Key Competitors 23 Alliqua BioMedical, Inc. - Key Employees 24 Alliqua BioMedical, Inc. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Recent Developments 26 Alliqua BioMedical, Inc., Recent Developments 26 May 10, 2016: Alliqua BioMedical Reports First Quarter Financial Results 26 Feb 23, 2016: Alliqua BioMedical Reports Fourth Quarter and Fiscal Year 2015 Financial Results 27 Nov 05, 2015: Alliqua BioMedical Reports Third Quarter Financial Results 28 Sep 24, 2015: Poster on Use of Biovance for Treatment of Venous Ulcers to be Featured at the Fall 2015 Symposium on Advanced Wound Care 30 Aug 06, 2015: Alliqua BioMedical Reports Second Quarter Financial Results 30 Jun 25, 2015: Alliqua Biomedical. Announces The Publication Of Results From A Biovance Use Registry Study In Wounds 32 Jun 03, 2015: Alliqua BioMedical Appoints Nino Pionati as Chief Strategy and Marketing Officer 32 May 14, 2015: Alliqua BioMedical Reports First Quarter Financial Results 33 May 06, 2015: Alliqua BioMedical Presents at the Spring 2015 Symposium on Advanced Wound Care 34 Apr 23, 2015: Alliqua BioMedical Announces Preliminary First Quarter 2015 Revenue Results & Updates Fiscal Year 2015 Revenue Guidance 35 Appendix 36 Methodology 36 About GlobalData 36 Contact Us 36 Disclaimer 36
List of Tables
Alliqua BioMedical, Inc. Pipeline Products and Clinical Trials Overview 7 Alliqua BioMedical, Inc. Pipeline Products by Equipment Type 7 Alliqua BioMedical, Inc. Pipeline Products by Indication 8 Alliqua BioMedical, Inc. Clinical Trials by Trial Status 8 Alliqua BioMedical, Inc., Key Facts 9 Alliqua BioMedical, Inc., Major Products and Services 10 Alliqua BioMedical, Inc. Number of Pipeline Products by Development Stage 11 Alliqua BioMedical, Inc. Pipeline Products Summary by Development Stage 12 Alliqua BioMedical, Inc. Clinical Trials by Trial Status 13 Alliqua BioMedical, Inc. Clinical Trials Summary 13 Extracellular Matrix - Product Status 14 Extracellular Matrix - Product Description 14 HepaMate - Product Status 15 HepaMate - Product Description 15 HepaMate Bioartificial Liver System - Product Status 16 HepaMate Bioartificial Liver System - Product Description 16 HepaMate Bioartificial Liver System - Safety and Efficacy, Prospective, Randomized, Controlled Clinical Trail of Hepamate Bioartificial Liver System 17 Interfyl Human Connective Tissue Matrix - Product Status 18 Interfyl Human Connective Tissue Matrix - Product Description 18 PHN Patch - Product Status 19 PHN Patch - Product Description 19 PHN Patch - Clinical Study Of Transdermal Pain Patch For Treatment Of Post-Herpetic Neuralgia (PHN) Pain 20 SEPET Liver Assist Device - Product Status 21 SEPET Liver Assist Device - Product Description 21 Tissue Repair Scaffold - Product Status 22 Tissue Repair Scaffold - Product Description 22 Alliqua BioMedical, Inc., Key Employees 24 Alliqua BioMedical, Inc., Subsidiaries 25


List of Figures
Alliqua BioMedical, Inc. Pipeline Products by Equipment Type 8 Alliqua BioMedical, Inc. Pipeline Products by Development Stage 11 Alliqua BioMedical, Inc. Clinical Trials by Trial Status 13

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption rat

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify